Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Copenhagen - Delayed Quote DKK

Scandinavian Medical Solutions A/S (SMSMED.CO)

Compare
4.3000
+0.0100
+(0.23%)
At close: April 16 at 4:45:07 PM GMT+2
Loading Chart for SMSMED.CO
  • Previous Close 4.2900
  • Open 4.2800
  • Bid 4.1000 x --
  • Ask 4.3000 x --
  • Day's Range 4.1100 - 4.3000
  • 52 Week Range 3.6300 - 7.7400
  • Volume 9,036
  • Avg. Volume 31,836
  • Market Cap (intraday) 119.055M
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 15.36
  • EPS (TTM) 0.2800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide. It offers equipment in the categories of CATH lab, CT, linear accelerator, mammography, PET/CT, SPECT/CT, X-ray, ultrasound, MRI, Gamma/SPECT, C-arm, mobile X-ray, R/F, and others, as well as provides CT, MRI, CATH lab, X-ray, MAMMO, PET/CT, and C-arm parts. The company also provides equipment rental and technical services. It serves hospitals, medical clinics, and distributors. The company was incorporated in 2018 and is based in Aalborg, Denmark.

www.scandinavian-medical.com

26

Full Time Employees

September 30

Fiscal Year Ends

Recent News: SMSMED.CO

View More

Performance Overview: SMSMED.CO

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

SMSMED.CO
27.85%
OMX Copenhagen 25 Index (^OMXC25)
0.00%

1-Year Return

SMSMED.CO
44.44%
OMX Copenhagen 25 Index (^OMXC25)
16.48%

3-Year Return

SMSMED.CO
17.15%
OMX Copenhagen 25 Index (^OMXC25)
0.00%

5-Year Return

SMSMED.CO
22.66%
OMX Copenhagen 25 Index (^OMXC25)
33.73%

Compare To: SMSMED.CO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SMSMED.CO

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    119.06M

  • Enterprise Value

    147.30M

  • Trailing P/E

    15.36

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    1.44

  • Enterprise Value/Revenue

    0.65

  • Enterprise Value/EBITDA

    6.53

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.44%

  • Return on Assets (ttm)

    5.08%

  • Return on Equity (ttm)

    9.92%

  • Revenue (ttm)

    226.68M

  • Net Income Avi to Common (ttm)

    7.79M

  • Diluted EPS (ttm)

    0.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11M

  • Total Debt/Equity (mrq)

    47.58%

  • Levered Free Cash Flow (ttm)

    -18.32M

Research Analysis: SMSMED.CO

View More

Company Insights: SMSMED.CO

Research Reports: SMSMED.CO

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.